Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visuospatial Divided Attention
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Medical Review Officer Manual
Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention Medical Review Officer Manual for Federal Agency Workplace Drug Testing Programs EFFECTIVE OCTOBER 1, 2010 Note: This manual applies to Federal agency drug testing programs that come under Executive Order 12564 dated September 15, 1986, section 503 of Public Law 100-71, 5 U.S.C. section 7301 note dated July 11, 1987, and the Department of Health and Human Services Mandatory Guidelines for Federal Workplace Drug Testing Programs (73 FR 71858) dated November 25, 2008 (effective October 1, 2010). This manual does not apply to specimens submitted for testing under U.S. Department of Transportation (DOT) Procedures for Transportation Workplace Drug and Alcohol Testing Programs (49 CFR Part 40). The current version of this manual and other information including MRO Case Studies are available on the Drug Testing page under Medical Review Officer (MRO) Resources on the SAMHSA website: http://www.workplace.samhsa.gov Previous Versions of this Manual are Obsolete 3 Table of Contents Chapter 1. The Medical Review Officer (MRO)........................................................................... 6 Chapter 2. The Federal Drug Testing Custody and Control Form ................................................ 7 Chapter 3. Urine Drug Testing ...................................................................................................... 9 A. Federal Workplace Drug Testing Overview.................................................................. -
Chapter Four – TRPA1 Channels: Chemical and Temperature Sensitivity
CHAPTER FOUR TRPA1 Channels: Chemical and Temperature Sensitivity Willem J. Laursen1,2, Sviatoslav N. Bagriantsev1,* and Elena O. Gracheva1,2,* 1Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA 2Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA *Corresponding author: E-mail: [email protected], [email protected] Contents 1. Introduction 90 2. Activation and Regulation of TRPA1 by Chemical Compounds 91 2.1 Chemical activation of TRPA1 by covalent modification 91 2.2 Noncovalent activation of TRPA1 97 2.3 Receptor-operated activation of TRPA1 99 3. Temperature Sensitivity of TRPA1 101 3.1 TRPA1 in mammals 101 3.2 TRPA1 in insects and worms 103 3.3 TRPA1 in fish, birds, reptiles, and amphibians 103 3.4 TRPA1: Molecular mechanism of temperature sensitivity 104 Acknowledgments 107 References 107 Abstract Transient receptor potential ankyrin 1 (TRPA1) is a polymodal excitatory ion channel found in sensory neurons of different organisms, ranging from worms to humans. Since its discovery as an uncharacterized transmembrane protein in human fibroblasts, TRPA1 has become one of the most intensively studied ion channels. Its function has been linked to regulation of heat and cold perception, mechanosensitivity, hearing, inflam- mation, pain, circadian rhythms, chemoreception, and other processes. Some of these proposed functions remain controversial, while others have gathered considerable experimental support. A truly polymodal ion channel, TRPA1 is activated by various stimuli, including electrophilic chemicals, oxygen, temperature, and mechanical force, yet the molecular mechanism of TRPA1 gating remains obscure. In this review, we discuss recent advances in the understanding of TRPA1 physiology, pharmacology, and molecular function. -
The Emerging Role of Transient Receptor Potential Channels in Chronic Lung Disease
BACK TO BASICS | TRANSIENT RECEPTOR POTENTIAL CHANNELS IN CHRONIC LUNG DISEASE The emerging role of transient receptor potential channels in chronic lung disease Maria G. Belvisi and Mark A. Birrell Affiliation: Respiratory Pharmacology Group, Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK. Correspondence: Maria G. Belvisi, Respiratory Pharmacology Group, Airway Disease Section, National Heart and Lung Institute, Imperial College, Exhibition Road, London SW7 2AZ, UK. E-mail: [email protected] @ERSpublications Transient receptor potential channels are emerging as novel targets for chronic lung diseases with a high unmet need http://ow.ly/GHeR30b3hIy Cite this article as: Belvisi MG, Birrell MA. The emerging role of transient receptor potential channels in chronic lung disease. Eur Respir J 2017; 50: 1601357 [https://doi.org/10.1183/13993003.01357-2016]. ABSTRACT Chronic lung diseases such as asthma, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis are a major and increasing global health burden with a high unmet need. Drug discovery efforts in this area have been largely disappointing and so new therapeutic targets are needed. Transient receptor potential ion channels are emerging as possible therapeutic targets, given their widespread expression in the lung, their role in the modulation of inflammatory and structural changes and in the production of respiratory symptoms, such as bronchospasm and cough, seen in chronic lung disease. Received: Jan 08 2017 | Accepted after revision: April 14 2017 Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com Copyright ©ERS 2017 https://doi.org/10.1183/13993003.01357-2016 Eur Respir J 2017; 50: 1601357 TRANSIENT RECEPTOR POTENTIAL CHANNELS IN CHRONIC LUNG DISEASE | M.G. -
The Cannabinoid Receptor Agonist WIN 55,212-2 Attenuates the Effects Induced by Quinolinic Acid in the Rat Striatum
Neuropharmacology 51 (2006) 1004e1012 www.elsevier.com/locate/neuropharm The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum A. Pintor a, M.T. Tebano a, A. Martire a, R. Grieco a, M. Galluzzo a, M.L. Scattoni b,A.Pe`zzola a, R. Coccurello c, F. Felici a, V. Cuomo d, D. Piomelli e, G. Calamandrei b, P. Popoli a,* a Department of Drug Research and Evaluation, Central Nervous System Pharmacology Division, Istituto Superiore di Sanita`, Viale Regina Elena, 299, 00161 Rome, Italy b Department of Cell Biology and Neuroscience, Istituto Superiore di Sanita`, Viale Regina Elena, 299, 00161 Rome, Italy c Institute of Neuroscience, EBRI Foundation, Rome, Italy d Department of Pharmacology and General Physiology, University ‘‘La Sapienza’’, Rome, Italy e Department of Pharmacology and Center for Drug Discovery, University of California, Irvine, CA, USA Received 7 April 2006; received in revised form 15 May 2006; accepted 16 June 2006 Abstract The ability of CB1 receptors to regulate the release of glutamate in the striatum, together with the finding that, in experimental models of Huntington disease (HD), both endocannabinoid levels and CB1 receptor densities are reduced, has prompted the investigation on the neuropro- tective role of the cannabinoids in HD. Quinolinic acid (QA) is an excitotoxin that, when injected in the rat striatum reproduces many features of HD and that acts by stimulating glutamate outflow. The aim of the present study was to test the ability of the cannabinoid receptor agonist WIN 55,212-2 to prevent the effects induced by QA in the rat striatum. -
Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles. -
* * * Chemical Agent * * * Instructor's Manual
If you have issues viewing or accessing this file contact us at NCJRS.gov. · --. -----;-:-.. -----:-~------ '~~~v:~r.·t..~ ._.,.. ~Q" .._L_~ •.• ~,,,,,.'.,J-· .. f.\...('.1..-":I- f1 tn\. ~ L. " .:,"."~ .. ,. • ~ \::'J\.,;;)\ rl~ lL/{PS-'1 J National Institute of Corrections Community Corrections Division * * * CHEMICAL AGENT * * * INSTRUCTOR'S MANUAL J. RICHARD FAULKNER, JR. CORRECTIONAL PROGRAM SPECIALIST NATIONAL INSTITUTE OF CORRECTIONS WASIHNGTON, DC 20534 202-307-3106 - ext.138 , ' • 146592 U.S. Department of Justice National Institute of Justice This document has been reproduced exactly as received from the person or organization originating it. Points of view or opinions stated In tl]!::; document are those of the authors and do not necessarily represent the official position or policies of the National Institute of Justice. Permission to reproduce this "'"P 'J' ... material has been granted by Public Domain/NrC u.s. Department of Justice to the National Criminal Justice Reference Service (NCJRS). • Further reproduction outside of the NCJRS system reqllires permission of the f ._kt owner, • . : . , u.s. Deparbnent of Justice • National mstimte of Corrections Wtulringttm, DC 20534 CHEMICAL AGENTS Dangerous conditions that are present in communities have raised the level of awareness of officers. In many jurisdictions, officers have demanded more training in self protection and the authority to carry lethal weapons. This concern is a real one and administrators are having to address issues of officer safety. The problem is not a simple one that can be solved with a new policy. Because this involves safety, in fact the very lives of staff, the matter is extremely serious. Training must be adopted to fit policy and not violate the goals, scope and mission of the agency. -
Endocannabinoid Stimulated Release of Nitric Oxide and Its Mitochondrial
A tica nal eu yt c ic a a m A r a c t Stefano et al., Pharm Anal Acta 2015, 6:6 h a P Pharmaceutica Analytica Acta DOI: 10.4172/2153-2435.1000378 ISSN: 2153-2435 Review Article Open Access Endocannabinoid Stimulated Release of Nitric Oxide and its Mitochondrial Influence Triggering Vascular Pathology George B Stefano*, Erin Quinn and Richard M Kream MitoGenetics LLC, 3 Bioscience Park Drive, Suite 307, Farmingdale, NY 11735, USA Abstract Endocannabinoids, and their respective receptors, are involved in a host of cellular regulatory activities. In part, some of these mediated effects occur by way of stimulating constitutive nitric oxide release. This occurs in endothelia, certain white blood cells, microglia, and in similar invertebrate tissues, demonstrating that this is a conserved chemical messenger system. This endocannabinoid chemical messenger system, coupled to constitutive nitric oxide release, also appears to exert regulatory effects on mitochondrial energy associated processes, further substantiating its primordial history. In this regard, it appears to offer some beneficial actions in the occurrence of reperfusion injury and stroke. The mechanism envisioned is one initiated via a hypoxic event, which does not restore normalcy, then progresses to a pro-inflammatory state, and the resultant chronic condition manifests itself in a specific disorder. This fits nicely into a vascular-associated origin for Alzheimer’s Disease, whereby the pro- inflammatory state encompasses vessels that have endothelial gaps, providing for a compromised blood brain barrier, beta amyloid deposition, and enhanced white blood cell trafficking. In time, due to the physical progression of the events, Alzheimer’s Disease occurs. -
The Effects of Ketamine on Dopaminergic Function: Meta-Analysis and Review of the Implications for Neuropsychiatric Disorders
OPEN Molecular Psychiatry (2018) 23, 59–69 www.nature.com/mp REVIEW The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders M Kokkinou1,2, AH Ashok1,2,3 and OD Howes1,2,3 Ketamine is a non-competitive antagonist at the N-methyl-D-aspartate receptor. It has recently been found to have antidepressant effects and is a drug of abuse, suggesting it may have dopaminergic effects. To examine the effect of ketamine on the dopamine systems, we carried out a systematic review and meta-analysis of dopamine measures in the rodent, human and primate brain following acute and chronic ketamine administration relative to a drug-free baseline or control condition. Systematic search of PubMed and PsychInfo electronic databases yielded 40 original peer-reviewed studies. There were sufficient rodent studies of the acute effects of ketamine at sub-anaesthetic doses for meta-analysis. Acute ketamine administration in rodents is associated with significantly increased dopamine levels in the cortex (Hedge’s g = 1.33, Po0.01), striatum (Hedge’s g = 0.57, Po0.05) and the nucleus accumbens (Hedge’s g = 1.30, Po0.05) compared to control conditions, and 62–180% increases in dopamine neuron population activity. Sub-analysis indicated elevations were more marked in in vivo (g = 1.93) than ex vivo (g = 0.50) studies. There were not enough studies for meta-analysis in other brain regions studied (hippocampus, ventral pallidum and cerebellum), or of the effects of chronic ketamine administration, although consistent increases in cortical dopamine levels (from 88 to 180%) were reported in the latter studies. -
Nitrous Oxide (N2O) Isotopic Composition in the Troposphere: Instrumentation, Observations at Mace Head, Ireland, and Regional Modeling
Nitrous oxide (N2O) isotopic composition in the troposphere: instrumentation, observations at Mace Head, Ireland, and regional modeling by Katherine Ellison Potter B.S. Chemistry & Environmental Science College of William and Mary, 2004 SUBMITTED TO THE DEPARTMENT OF EARTH, ATMOSPHERIC, AND PLANETARY SCIENCES IN PARTIAL FULFULLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN CLIMATE PHYSICS AND CHEMISTRY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY SEPTEMBER 2011 © 2011 Massachusetts Institute of Technology. All rights reserved. Signature of Author: _____________________________________________________________ Department of Earth, Atmospheric, and Planetary Sciences 19 August 2011 Certified by: ___________________________________________________________________ Ronald G. Prinn TEPCO Professor of Atmospheric Chemistry Thesis Supervisor Certified by: ___________________________________________________________________ Shuhei Ono Assistant Professor Thesis Co-Supervisor Accepted by: ___________________________________________________________________ Maria T. Zuber E.A. Griswold Professor of Geophysics and Planetary Science Department Head 2 Nitrous oxide (N2O) isotopic composition in the troposphere: instrumentation, observations at Mace Head, Ireland, and regional modeling by Katherine Ellison Potter Submitted to the Department of Earth, Atmospheric, and Planetary Sciences on 19 August 2011 in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Climate Physics and Chemistry Abstract Nitrous -
Ambient Formaldehyde Measurements Made at A
Ambient formaldehyde measurements made at a remote marine boundary layer site during the NAMBLEX campaign ? a comparison of data from chromatographic and modified Hantzsch techniques T. J. Still, S. Al-Haider, P. W. Seakins, R. Sommariva, J. C. Stanton, G. Mills, S. A. Penkett To cite this version: T. J. Still, S. Al-Haider, P. W. Seakins, R. Sommariva, J. C. Stanton, et al.. Ambient formaldehyde measurements made at a remote marine boundary layer site during the NAMBLEX campaign ? a comparison of data from chromatographic and modified Hantzsch techniques. Atmospheric Chemistry and Physics, European Geosciences Union, 2006, 6 (9), pp.2711-2726. hal-00295970 HAL Id: hal-00295970 https://hal.archives-ouvertes.fr/hal-00295970 Submitted on 6 Jul 2006 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Atmos. Chem. Phys., 6, 2711–2726, 2006 www.atmos-chem-phys.net/6/2711/2006/ Atmospheric © Author(s) 2006. This work is licensed Chemistry under a Creative Commons License. and Physics Ambient formaldehyde measurements made at a remote marine boundary layer site during the NAMBLEX campaign – a comparison of data from chromatographic and modified Hantzsch techniques T. -
Accepted Manuscript Provisional
Int J Case Rep Images 2015;6():**–**. Richtig et al. 1 www.ijcasereportsandimages.com ACASECCCEPTEASE REPORTD MAN USCRIPT PEERP EERREVI REEWVIEEDW |E PROD OPEN| OPENVISIONA ACCESS ACCESSL PDF Cannabis consumption before surgery may be associated with increased tolerance of anesthetic drugs: A case report Georg Richtig, Götz Bosse, Friederike Arlt, Christian von Heymann Disclaimer: This manuscript has been accepted for and anesthetic drugs like propofol and thiopental, publication in International Journal of Case Reports but the pharmacodynamic interaction between and Images (IJCRI). This is a pdf file of the provisional cannabis and commonly used anesthetic drugs is version of the manuscript. The manuscript will under still not well understood. Case Report: A 37-year go content check, copyediting/proofreading and content old male patient with a history of regular cannabis formating to conform to journal’s requirements. Please consumption and cannabis intake the day before note that during the above publication processes errors in surgery was admitted for an arthroscopic content or presentation may be discovered which will be shoulder stabilization. Induction of anesthesia rectified during manuscript processing. These errors may required large doses of propofol, thiopental and affect the contents of this manuscript and final published sevoflurane. MaintenancePDF was achieved with the version of this manuscript may be extensively different additional application of nitrous oxide to provide in content and layout than this provisional PDF version. clinical tolerance of the surgical procedure. Return of consciousness and the postoperative MANUSCRIPTcourse were uneventful. Conclusion: History ABSTRACT of cannabis intake should be taken into routine preoperative assessment and patients should Introduction: Cannabis is the most commonly be closely monitored by experienced anesthesia used illicit drug worldwide in adults. -
CLINICAL REVIEW Management of the Effects of Exposure to Tear
CLINICAL REVIEW For the full versions of these articles see bmj.com Management of the effects of exposure to tear gas Pierre-Nicolas Carron, Bertrand Yersin Service of Emergency Medicine, Despite the frequent use of riot control agents by Eur- solvent, and delivered with a dispersion vehicle (a University Hospital Center and opean law enforcement agencies, limited information pyrotechnically delivered aerosol or spray University of Lausanne, 1011 exists on this subject in the medical literature. The solution).45 Tear gases are not currently considered as Lausanne CHUV, Switzerland Correspondence to: P-N Carron effects of these agents are typically limited to minor chemical weapons by Western countries. Since the [email protected] and transient cutaneous inflammation, but serious 1950s, they have been mainly used by law enforcement complications and even deaths have been reported. agencies for crowd control purposes in most European Cite this as: BMJ 2009;338:b2283 doi:10.1136/bmj.b2283 During the 1999 World Trade Organisation meeting countries, including the United Kingdom, France, and at the 2001 Summit of the Americas in Quebec, Germany, and Switzerland. Tear gases are also used exposure to tear gas was the most common reason for in military training exercises to test the rapidity or effi- medical consultations.12 Primary and emergency care cacy of protective measures in the event of a chemical physicians play a role in the first line management of attack. patients as well as in the identification of those at risk of Of the known disabling chemical irritants (of which complications from exposure to riot control agents.